Tirzepatide
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
Eli Lilly · Phase 3 · Completed · Enrollment 731
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.